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Ichthyosis bullosa of Siemens : 
a distinct type of epidermolytic hyperkeratosis
W e report a case of ichthyosis o f Siemens (IBS) and describe the clinical and histopa- 
thological criteria to distinguish this phenotype from bullous ichthyosiform erythroder­
ma of Brocq. In the present case, electron microscopical examination did not reveal 
any tonofilament defects. The diagnosis o f ichthyosis bullosa of Siemens was unequi­
vocally established by molecular analysis demonstrating a mutation in the K2e gene. 
This keratin is expressed in the upper layers of the epidermis. In the present family, 
six individuals belonging to four successive generations were affected. Remarkably, all 
o f them showed in addition, a syndactyly of the second and third toe whereas this ano­
maly was absent in family members with a healthy skin. If this finding should be more 
than a chance association, it may represent an example of genetic linkage. (Key words: 
ichthyosis bullosa o f  Siemens, bullous ichthyosiform erythroderma o f  Brocq, epider­
molytic hyperkeratosis, K2e mutation, zygodactyly.)
Reprints: U. Lenzner.
In 1902 Brocq first described a case of bullous congenital ichthyo­siform erythroderma, a phenotype characterized by congenital erythroderma, intermittent blistering and dark or greyish hyperke­
ratosis predominantly involving the flexor areas such as knees and the 
elbows as well as the dorsal aspects of hands and feet [1]. Thirty-five 
years later Siemens reported on a considerably less severe ichthyosis 
characterized by bulla formation [2]. All of these phenotypes showed 
an autosomal dominant mode of inheritance [1-3].
In contrast to bullous congenital ichthyosiform erythroderma 
(BCIE), however, patients affected with IBS do not have a history 
of post-neonatal erythroderma. The hyperkeratosis is milder, and the 
blistering mostly involves the upper part of the legs. As a characte­
ristic feature, IBS patients show denuded areas on a hyperkeratotic 
background, the so-called “Mauserung” phenomenon [2, 4, 5]. 
During the past decade, further cases of IBS have been reported, but 
the question of nosological classification has so far not been settled. 
Some authors describe IBS as a distinct entity [4-7), but others favor 
the concept that this phenotype merely represents a clinical variant 
of bullous ichthyosiform erythroderma of Brocq [8, 91, whereas a 
third group of authors believes that their cases represent new entities 
to be distinguished from both the Siemens and Brocq types of bul­
lous ichthyosis [10-12]. This report and the results of other studies 
[13] have now provided firm evidence that IBS is a unique type of 
epidermolytic ichthyosis. The mutation in IBS was found in the 
keratin 2e while in BCIE mutations in keratin I and 10 are found.
Figure 1. Pedigree showing autosomal dominant transmission of ich­
thyosis bullosa of Siemens. The trait segregates together with zygodacty­
ly of the second and third toes: ■: affected nude: 1): affected female; 
A: died some days after birth; *: Propositus; t>; Syndactyly.
Case report
The patient was a 21-year-old man who suffered from blistering of 
the skin since his third year of life. His father and his 24-year-old 
sister were similarly affected but had noticed some improvement of 
the disease during adulthood. During childhood intermittent periods 
of superinfection had occurred to a degree that the family believed 
that they were especially prone to an infectious skin disease. The 
mother of the patient reported that a first-born child, a boy, had died 
some days after birth from a “burned skin syndrome”. The patient’s 
grandfather and great-grandmother were likewise affected (Fig. I). 
All of the infected individuals showed, in addition, a zygodactyly of 
their second and third toes. The proband consulted us because he 
had developed blistering on the dorsal aspect on his upper legs after 
having marched in boots over a distance of 12 km.
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On physical examination, his shanks were swollen and showed brui­
sing and multiple erosions with superinfection. Brownish hyperkera­
tosis was present in the axillary, gluteal and periumbilical region 
(Figs. 2 to 4) and resulted in a rippled appearance especially on the 
flexural aspects of his elbows and knees. Superficially denuded 
areas of 2 cm diameter were noted (Fig. 3). The patient showed, in 
addition, bilateral zygodactyly of his second and third toes. 
Histopathological examination of a biopsy obtained from the right 
upper leg revealed orthohyperkeratosis and acanthosis. In the upper 
layers of the epidermis, a granular degeneration of keratinocytes 
with perinuclear halo formation was noted (Fig. 5 and 6j.
Electron microscopical examination of a biopsy obtained from a 
blistering area (right shank) showed intra-epidermal cleavage resul­
ting in a blister reaching from the basal layer to the stratum granulo- 
sum. The lumen was filled with erythrocytes and neutrophils as well
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The concept that IBS represents a distinct entity within the spectrum 
of phenotypes characterized by EH, has now been confirmed at the 
molecular level. EH of the Brocq type, either with congenital ery­
throderma (BCIE) or without erythroderma reveals mutations in the 
type II keratins K1 and K10 that are localized on chromosome I2q 
[16-20]. These keratins are expressed in the basal and suprabasal 
layers of the epidermis [18]. By contrast, the mutation causing IBS 
was found in keratin 2e which is likewise localized in the granular 
and upper spinous layer [13, 21-23], This finding demonstrates that 
IBS is an entity to be distinguished from BCIE [13].
Because of the varying nomenclature and variable clinical appearan­
ce of this phenotype, it is difficult to determine how many cases of 
IBS have previously been reported in the literature. For example, 
McGrath et at. [10] have proposed, even in 1991, the name “bullous 
ichthyosis1' as a unifying term for all cases of ichthyosis showing 
the histopathological of EH. Their familial observation can now be 
categorized as IBS, Other case reports [9, 11] are more difficult to 
categorize. For example, a patient observed by Murdoch and Leigh 
[9] had typical features of IBS but showed, in addition, “a back­
ground erythroderma, albeit variable”. On the other hand Gasser [3] 
has pointed out that clinical signs of blistering may be absent in 
BCIE although histological features of blistering can be documen­
ted.
Vakilzadeh and Kolde [12] described a family affected with “auto­
somal dominant ichthyosis exfoliativa”. The clinical feature were 
similar to IBS, but electron microscopical examination failed to 
reveal any defect of tonofilaments. According to recent data, howe­
ver, this family observation has been recognized as a case of IBS 
because a mutation in the keratin 2e gene has been documented. A 
second ultrastructural examination could show tonofilament clum­
ping focally in the upper spinous layer [13]. In the present case, 
ultrastructural features of a tonofilament defect were likewise 
absent, although a K2e mutation has been demonstrated [13]. Possi­
bly in this case the lack of tonofilament clumping also depended on 
the biopsy site.
Because keratins are major structural proteins of the epidermis, the 
identified keratin mutation may be regarded as the cause of the 
disease. The blistering observed in EH results from a disturbed 
architecture of keratin filaments [24, 25], Letai et a l  [25] pointed 
out that the degree of severeness of blistering, resulting in either 
epidermolysis bullosa simplex or bullous ichthyosis, depends on the 
nature of the mutation. They found a correlation between severe 
BCIE and mutations within the highly conserved rod domains of 
major keratin genes [25]. By contrast, milder cases of this phenoty­
pe are mapped to less conserved regions either within or outside the 
rod domain [16]. In the present case, the underlying mutation was 
found in a highly conserved region, namely in the 2 B rod domain. 
We can speculate that a point mutation in K2e always implicates a 
mild clinical picture because of the nature of this keratin which is 
expressed in the granular and upper spinous layer. It would be inter­
esting to know which mutations were at the origin of some pre­
viously published cases that are difficult to classify [9, 11],
In the present case, a brother of the proband died some days after 
birth from an alleged “burned skin syndrome”. It is difficult to eva­
luate this point of the case history because congenital erythroderma 
is typical of BCIE but not of IBS [3-5]. Moreover, congenital ery­
throderma present in BCIE is not usually a lethal disorder. 
Remarkably, all affected individuals of the present family showed 
zygodactyly of their second and third toes whereas family members 
with a healthy skin did not show this trait. If this phenomenon is not 
a mere coincidence, it can be best explained as an example of linka­
ge inheritance. The mutation responsible for zygodactyly would be 
present on a gene locus neighbouring the IBS gene. If this concept 
holds true, the present family observation could be taken as a first 
step in gene mapping of a rather frequent trait, zygodactyly.
Topical treatment is, so far, more important than administration of 
oral drugs. In order to ensure a keratolytic effect, urea, propylene gly­
col or vitamin A acid may be applied whereas sodium chloride or lac­
tic acid exert a beneficial effect by hydration of the horny layer [7]. A 
first report on oral treatment of IBS with acitretin given at a low 
dosage appears to be promising [6]. A dosage of 35 mg/day resulted 
in a marked decrease of hyperkeratosis without any increase of bliste­
ring. From the oral retinoid treatment of BCIE patients it is known 
that increased blistering may occur even at a dosage of 0.7 mg/kg/day 
[26] but some authors have reported a substantial improvement with 
0.6 mg/kg/day [27].
The clinical, histopathological and molecular delineation of IBS is 
important for a precise diagnosis and appropriate genetic counsel­
ling. The demonstration of a K2e mutation allows the prediction that 
the skin involvement should be milder than in that observed in 
BCIE. Furthermore, a prenatal diagnosis no longer depends on mor­
phological analysis of a fetal skin biopsy [28]. If the underlying 
mutation is known, a diagnosis of IBS can be established or exclu­
ded by obtaining fetal cells through amnioncentesis or at an earlier 
stage by chorion villus sampling [16, 20].
Zusammenfassung
Wir berichten über einen Fall von Ichthyosis bullosa vom Typ Sie­
mens (IBS) und beschreiben die klinischen und histologischen Krite­
rien, um diesen Phänotyp von der ichthyosiformen Erythrodermie 
vom Typ Brocq abzugrenzen. Im vorliegenden Fall zeigte sich in der 
elektronenmikroskopischen Untersuchung kein Defekt der Tonofila- 
mente, Die Diagnose der Ichthyosis bullosa vom Typ Siemens wurde 
hier zweifelsfrei durch die molekulare Analyse einer Mutation im 
K2e-Gen gestellt. Dieses Kreatin ist in den oberen Lagen der Epider­
mis zu finden. In der hier untersuchten Familie sind 6 Mitglieder in 
4 Generationen erkrankt. Zusätzlich zu der IBS hatten alle erkrank­
ten Familienmitglieder eine Syndaktylie der 2. und 3. Zehe, während 
dieser Befund bei keinem Familienmitglied mit gesunder Haut zu 
finden war. Wenn es sich bei diesem Befund um mehr als einen 
Zufall handelt, könnte er als Beispiel für eine gekoppelte Vererbung 
stehen.
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